Cervical Artery Dissections: Etiopathogenesis and Management

• Published in: Vascular health and risk management 2022-01, Vol.18, p.685-700
• Main Authors: Keser, Zafer, Chiang, Chia-Chun, Benson, John C, Pezzini, Alessandro, Lanzino, Giuseppe
• Format: Article
• Language: English
• Subjects: Asymptomatic; Carotid arteries; cervical artery dissection; Collagen; Connective tissue; Dissection; Etiology; genetics; Headache - etiology; Headache - therapy; Health aspects; Hematoma; Humans; Industrial equipment and supplies industry; Medical education; Middle age; Migraine; Neck pain; Pathophysiology; Patients; Pseudoaneurysm; Review; Risk Factors; Spinal manipulation; Stroke; Stroke - etiology; Stroke - prevention & control; Surgery; Tinnitus; Trauma; Vein & artery diseases; Vertebral Artery Dissection - complications; Vertebral Artery Dissection - therapy
• ISSN: 1178-2048; 1176-6344; 1178-2048
• DOI: 10.2147/VHRM.S362844

Cervical Artery Dissection (CeAD) is a frequent stroke etiology for patients younger than 50 years old. The most common immediate complications related to CeAD are headache and neck pain (65-95%), TIA/ischemic stroke (>50%), and partial Horner's syndrome (25%). The prevailing hypothesis regarding the pathogenesis of sCeAD is that the underlying constitutional vessel wall weakness of patients with sCeAD is genetically determined and that environmental factors could act as triggers. The stroke prevention treatment of CeAD remains controversial, involving anticoagulation or antiplatelet therapy and potentially emergent stenting and/or thrombectomy or angioplasty for selected cases of carotid artery dissection with occlusion. The treatment of headache associated with CeAD depends on the headache phenotype and comorbidities. Radiographically, more than 75% of CeAD cases present with occlusion or non-occlusive stenosis. Many patients demonstrate partial and complete healing, more commonly in the carotid arteries. One-fifth of the patients develop dissecting pseudoaneurysm, but this is a benign clinical entity with an extremely low rupture and stroke recurrence risk. Good recovery is achieved in many CeAD cases, and mortality remains low. Family history of CeAD, connective tissue disorders like Ehlers-Danlos syndrome type IV, and fibromuscular dysplasia are risk factors for recurrent CeAD, which can occur in 3-9% of the cases. This review serves as a comprehensive, updated overview of CeAD, emphasizing etiopathogenesis and management.